⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Global Bispecific Antibody Market Intelligence & Growth Forecast to 2031: Opportunity, Dosage, Patents, Pricing, Sales, and Clinical Trials | Market to Top USD 60 Billion as 550+ Candidates Advance
globenewswire.com
JNJ
AMGN
ABBV
PFE
BMY
XNCR
ZYME
REGN
GILD
MRK
AZN
LULU
ROST
MDT
BIIB
VRTX
ALNY
CRSP
NTLA
EDIT
SRPT
NVO
SNY
LLY
TEVA
BHC
GNTX
Global Semi-Solid Dosage Drugs Market Size, Share and Trends, 2026-2033 | USD 14.16 Billion Opportunity Fueled by Topical Innovation, Aging Populations, and Online Pharmacy Growth
globenewswire.com
PFE
GSK
JNJ
VTRS
TEVA
BHC
SUN
SNY
Clinical Trial Supply and Logistics Market Forecast to Reach USD 8.58 Billion by 2034 as Biologics, Global Trials and Cold-Chain Requirements Reshape Supply Networks
globenewswire.com
CAT
AMZN
AMGN
BMY
CRIS
EXPE
FDX
GILD
IQV
LLY
MRK
NVS
PFE
REGN
SNY
TEVA
UPS
VRTX
Interact joins Anthropic’s Cyber Verification Program to strengthen enterprise intranet security with Claude Mythos 5.1
globenewswire.com
MSFT
GOOGL
LEVI
DPZ
TEVA
$CDNL Stock Market Alert: Cardinal Infrastructure Investigated for Securities Fraud after Acquisition Issues Lead to 36% Stock Drop – Contact BFA Law if You Lost Money
globenewswire.com
CDNL
TSLA
TEVA
BIO-Europe 2026 to Convene Global Biopharma Leaders in Cologne as Dealmaking Confidence Grows
globenewswire.com
TEVA
Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline
globenewswire.com
TEVA
BIIB
Interact brings 700 intranet capabilities to enterprise AI assistants with Interact MCP
globenewswire.com
MSFT
TEVA
$CC Stock Losses: BFA Law Reminds Chemours Investors with Losses of the Ongoing Securities Fraud Class Action that Alleges Opteon Demand Misrepresentations
globenewswire.com
CC
TSLA
TEVA
Middle East and Africa Biosimilars Market Forecast to 2035 - Industry Trends and Competitive Analysis | Patent Expiries Drive 19% CAGR and a USD 5.73 Billion Opportunity
globenewswire.com
ABBV
AMGN
PFE
TEVA
VTRS